Jane Adetifa

Learn More
BACKGROUND Measles vaccine in early infancy followed by a dose at 9 months of age protects against measles and enhances child survival through non-specific effects. Little is known of immune responses in the short or long term after booster doses. METHODS Infants were randomized to receive measles vaccine at 9 months of age (group 1) or 4 and 9 months of(More)
  • 1